Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Directorate Change

27 May 2008 16:00

RNS Number : 3276V
W.H. Ireland Group PLC
27 May 2008
 



WH Ireland Group plc

("WH Ireland" or the "Company")

Appointment of Non-Executive Director

Further to the announcement on 14 May 2008 and following receipt of approvals from the FSA, WH Ireland is pleased to announce the appointment of Roland Rudd as a Non-Executive Director with effect from 27 May 2008.

Roland Dacre Rudd, aged 47 years, is co-founder and Senior Partner of Finsbury Limited and Non-Executive Director of Breakingviews Limited. Roland is the founding Chairman of Business for New Europe, the Chairman of NSPCC's Stop Organised Abuse, Chairman of the Tate's Corporate Advisory Body and on the Board of the Royal Opera House Development Committee.

Roland is also a Director of Finsbury.com Limited, Ingenious Games LLP, Millfield Foundation and Policy Network and Communications Limited. Formerly Roland was a board member of Britain in Europe and Managing Editor (Business) of The Sunday Correspondent.

As at the date of this announcement, Roland holds 485,713 ordinary shares of 5 pence each in the Company.

There is no further information to be disclosed under Schedule 2(g) of the AIM rules.

For further information, please contact:-

Rupert Lowe

Zoe Biddick

WH Ireland Group plc

Biddicks

0161 819 8750

020 7448 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABSGDULGDGGIR
Date   Source Headline
15th Aug 20232:59 pmRNSResult of General Meeting and Total Voting Rights
31st Jul 20237:25 amRNSPosting of Circular and Notice of General Meeting
28th Jul 20238:53 amRNSResult of Placing
28th Jul 20237:00 amRNSTrading Update & Proposed Placing
22nd Jun 20239:05 amRNSESOT Purchases
15th Jun 20234:57 pmRNSESOT Purchases
24th Apr 20232:11 pmRNSESOT Purchases
21st Apr 20239:20 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSIssue of Equity
3rd Apr 20237:00 amRNSYear End Trading Update
14th Mar 202311:39 amRNSESOT Purchases
9th Feb 20239:10 amRNSESOT Trading
25th Jan 20238:47 amRNSTotal Voting Rights
17th Jan 20238:44 amRNSESOT Purchases
11th Jan 202310:45 amRNSIssue of Equity - Total Voting Rights
20th Dec 20222:08 pmRNSTR-1: Notification of major holdings
16th Dec 202210:19 amRNSRecent appointments across the Group
16th Dec 20227:00 amRNSInterim Results
7th Dec 20227:00 amRNSESOT Purchases
7th Nov 20225:00 pmRNSESOT Trading
4th Nov 20223:45 pmRNSESOT Trading
4th Oct 20228:18 amRNSESOT Purchases
8th Sep 20224:10 pmRNSResult of AGM
8th Sep 20228:23 amRNSESOT Purchases
5th Aug 20227:00 amRNSESOT Purchases
1st Aug 202210:18 amRNSPDMR Shareholding
27th Jul 20227:00 amRNSFinal Results and Notice of AGM
19th Jul 20227:00 amRNSConfirmation of Chairman Appointment
12th Jul 20227:00 amRNSESOT Purchases
20th Jun 20227:00 amRNSESOT Purchases
10th May 20227:00 amRNSNew Debt Capital Markets Business
6th May 20227:37 amRNSESOT Purchases
27th Apr 20224:05 pmRNSIssue of Options
12th Apr 20228:51 amRNSESOT Purchases
31st Mar 20227:00 amRNSBoard Changes
9th Mar 20227:00 amRNSESOT Purchases
17th Feb 202211:23 amRNSPDMR Shareholdings
15th Feb 20227:00 amRNSDirectorate Update
11th Feb 20224:47 pmRNSTR-1: Notification of Major Holdings
11th Feb 20227:00 amRNSTR-1: Notification of Major Holdings
10th Feb 20229:11 amRNSESOT Purchases
7th Feb 202212:39 pmRNSIssue of Equity - Total Voting Rights
24th Jan 20225:12 pmRNSPDMR Shareholdings
18th Jan 20227:00 amRNSPDMR Shareholding
13th Jan 20227:00 amRNSDirectorate Change
6th Jan 20227:00 amRNSESOT Purchases
20th Dec 20217:00 amRNSAppointment of Head of Private Growth Capital
17th Dec 202111:32 amRNSPrivate Capital Team Update
15th Dec 20217:00 amRNSESOT Purchases
7th Dec 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.